Furthermore, by performing Cox regression analysis on multiple GBM cohorts and multiple LGG cohorts, we found that the MAP2K3 gene was a significant risk factor for poor patient prognosis (Figures 3C,D). This evidence concerns the gene MAP2K3 and glioblastoma.